The Cost of Cancer Care: Navigation Challenges to Participation in Phase I Clinical Trials


  •  Wanda Strange    
  •  Shannon Cagnina    
  •  Cynthia Bedell    
  •  John Nemunaitis    

Abstract

Phase I trial participation for advanced cancer patients is often a “last resort” in an attempt to control progressive disease. It is also a necessary component mandated by our investigative community and FDA to characterize safety and mechanism via dose and schedule modulation of experimental therapeutics. Participation in phase I studies is difficult without support. The purpose of this assessment is to provide mechanisms of support established by nurse navigation to facilitate phase I trial patient participation.


This work is licensed under a Creative Commons Attribution 4.0 License.
  • ISSN(Print): 1927-4858
  • ISSN(Online): 1927-4866
  • Started: 2012
  • Frequency: semiannual

Journal Metrics

Google-based Impact Factor (2018): 3.94

h-index (August 2018): 8

i10-index (August 2018): 6

h5-index (August 2018): N/A  

h5-median(August 2018): N/A

(The data was calculated based on Google Scholar Citations. Click Here to Learn More. )

Contact